Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results

/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio," "we," or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve...

Related Keywords

China ,Japan ,United States ,Shenzhen ,Guangdong ,Qing Zhu ,Hunan ,Australia ,Shanghai ,Beijing ,Chinese ,Japanese ,America ,Taiyin Yang ,Fankang Li ,Brii Biosciences Bio ,Zhi Hong ,Susannah Cantrell ,Karend Neuendorff ,Brii Bio ,Aleksandar Skuban ,Chinese Pharmaceutical Listed Companies ,Bacteria Infections Program ,Risk Committee ,Clinical Development Updates ,Us Department Of Health ,Qpex Biopharma Inc ,Human Service ,Gold Bell Seal For Workplace Mental Health ,Public Health Emergency ,Lung Disease Program ,Maternal Mental Health Summit ,National Medical Products Administration ,Vir Biotechnology Inc ,Prnewswire Brii Biosciences Limited Bio ,Mom Annual Forum ,China Times ,Program China ,Therapeutics Ltd Beijing Co ,Vaccines Inc ,Strategy Committee ,Drug Administration ,Nasdaq ,Tsinghua University ,Maternal Mental Health ,Mental Health America ,Postpartum Support International Conference ,National Health Commission Of China ,Therapeutics Inc ,Biosciences Limited ,Chief Executive Officer ,Recent Corporate ,Chief Strategy ,Financial Officer ,Chief Business Officer ,Eleanor De Groot ,Chief Technology Officer ,Chief People ,China Research ,Rico Liang ,General Manager ,Small Cap Index ,Postpartum Support International ,Climb Out ,Annual Forum ,Maternal Mental Health Now ,Mental Health ,Forbes China ,Pharmaceutical Listed Companies ,Healthcare Executives ,Bell Seal ,Workplace Mental ,Pipeline Highlights ,Upcoming Milestones ,Vir Biotechnology ,Asian Pacific Association ,Ag Specifict Cell ,American Association ,Liver Diseases ,Drug Evaluation ,Major Depressive Disorder ,Investigational New Drug ,Pre Clinical Development ,Immunodeficiency Virus ,Extensively Drug Resistant ,Gram Negative Bacteria Infections ,Qualified Infectious Disease Product ,Lung Disease ,Treatment Guideline ,Treatment Protocol ,Emergency Use Authorization ,Biologics License Application ,Investor Relations ,Greater China ,Gram Negative Infections ,Third People ,National Health Commission ,Treatment Guidelines ,Delta Plus ,San Francisco Bay Area ,Brii Biosciences Limited ,